Published Jun 12, 2019

Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development

Member News

Related or similar articles

March 13, 2019

Labshares Newton Grows its Business​

Labshares is unveiling a major rennovation
Labshares News
June 12, 2019

Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development

The MoU was signed during the official, 40thanniversary celebration ceremony of the Shanghai-Rotterdam Sister City Relationship.
Member News
January 21, 2025

Labshares and Thermo Fisher Scientific Announce Five-Year Renewal and Expansion of Partnership

Press Releases